Search the Newsreel

Insider Selling: Disc Medicine (NASDAQ:IRON) COO Sells 804 Shares

Disc Medicine (NASDAQ:IRON) COO Jonathan Yen-Wen Yu recently sold 804 shares of the company's stock for $66,442.56, reducing his total holdings by 1.46%. This sale is part of a series of insider transactions since mid-June. Despite these sales, the company exceeded its recent quarterly …

Parabilis Medicines Inc. (PBLS) Stock Price | Live Quotes & Charts | NASDAQ

SBC Medical Group Holdings (SBC) Stock Reprices As Margins Power Profit Surge

Disc Medicine COO Jonathan Yu sells $66,444 in shares By Investing.com

Disc Medicine's COO, Jonathan Yu, sold 804 shares of the company's common stock for a total of $66,444 at an average price of $82.6425. This transaction was part of a pre-arranged trading plan, and it occurred as the stock had seen a 41% return …

Disc Medicine (NASDAQ: IRON) COO trades 804 shares via 10b5-1 plan

Disc Medicine's COO, Yu Jonathan Yen-Wen, exercised stock options for 804 shares at $13.50 each and simultaneously sold these 804 shares at a weighted average price of $82.6425. These transactions, which generated an approximate pre-tax spread of $56,000, were conducted under a pre-arranged Rule …

Is BeOne Medicines AG (ONC) Deal With Revolution Medicines (RVMD) a Win-Win for Both Companies?

Two oncology powerhouses, BeOne Medicines AG (NASDAQ:ONC) and Revolution Medicines, Inc. (NASDAQ:RVMD), announced a major multi-part clinical collaboration and regional licensing deal. Under the August 10 agreement, the companies will combine select clinical-stage assets from BeOne with Revolution's four clinical-stage RAS(ON) inhibitors to evaluate …

Journey Medical (DERM) Stock Eyes Break Even As Emrosi Gains Traction

Perceptive Advisors (NVNO) reports 3.5% beneficial stake via 24,605 warrants

Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. have reported a beneficial ownership of 3.5% in enVVeno Medical Corporation (NVNO) through 24,605 exercisable warrants. This stake represents 24,605 shares of common stock, based on 682,722 shares outstanding as of July …

Modular Medical, Inc. Q1 FY2027: Net loss $(6.49M), EPS $(1.19) — 10-Q Summary

Modular Medical, Inc. (MODD) reported a net loss of $(6.49M) for Q1 FY2027, an improvement from the prior year, with diluted loss per share at $(1.19). The company's cash and cash equivalents significantly decreased, leading to a flagged going-concern risk due to liquidity issues. …

Adagio Medical Receives Nasdaq Listing Deficiency Notice

ENvue Medical, Inc. SEC Filing (Aug 14, 2026)

ENvue Medical, Inc. has filed a Form 12b-25 Notification of Late Filing for its Quarterly Report on Form 10-Q for the period ended June 30, 2026. The company stated that additional time is needed to prepare, compile, and analyze supporting documentation to complete its …

Fuller & Thaler boosts disclosure of 5.19% ICU Medical (ICUI) ownership stake

Fuller & Thaler Asset Management, Inc. has filed an amended Schedule 13G, disclosing a 5.19% beneficial ownership stake in ICU Medical (ICUI). The firm holds 1,298,126.96 shares, with sole voting power over 1,276,819.96 shares and sole dispositive power over all 1,298,126.96 shares. The filing, …

Adagio Medical Holdings Disclosed Failure to Satisfy a Continued Listing Rule or Standard

Adagio Medical Holdings (ADGM) received a Nasdaq deficiency notice on August 13, 2026, for failing to meet the Listing Rule 5550(b)(1) requirement of at least $2.5 million in stockholders' equity, as their June 30, 2026 Form 10-Q reported equity of $(415,000). The notice does …

IceCure Medical (ICCM) expands 2024 employee share incentive reserve

IceCure Medical Ltd. has increased the ordinary shares reserved for its 2024 Employee Equity Incentive Plan by 2,500,000, bringing the new total to 2,612,667 ordinary shares. This expansion, approved by the board on August 11, 2026, provides additional capacity for future equity awards to …

Mobia Medical (MOBI) gets 11.1% ownership filing from Green Park & Golf group

Green Park & Golf Ventures II, LLC and affiliated entities have reported a beneficial ownership of 11.1% in Mobia Medical, Inc. (MOBI), totaling 3,684,409 shares. This stake is held across numerous LLCs, with managers Clay M. Heighten, MD, Carl D. Soderstrom, and Gilbert G. …

Profound Medical CFO Steps Down; Controller Takes Interim Role

Profound Medical (NASDAQ: PROF; TSX: PRN) has announced a management change, with Matthew Sobczyk, formerly Corporate Controller, promoted to Interim Chief Financial Officer. He succeeds Rashed Dewan, who has stepped down but will remain on a short-term consulting contract to ensure a smooth transition. …

Baker Bros. Advisors (RVMD) discloses 11.4M-share position in Revolution Medicines

Baker Bros. Advisors LP and related entities have reported a passive ownership stake of 5.3% in Revolution Medicines, Inc. This translates to beneficial ownership of 11,443,357 shares of common stock, held through investment funds Baker Brothers Life Sciences, L.P. and 667, L.P. The filing …

Parabilis Medicines (PBLS): ARCH Venture group discloses 6.4M-share, 5.3% ownership

ARCH Venture Fund XII and related entities have disclosed a 5.3% beneficial ownership stake in Parabilis Medicines (PBLS), amounting to 6,412,780 shares of common stock. This Schedule 13G filing indicates a passive investment, with ARCH Venture Partners XII, L.P., ARCH Venture Partners XII, LLC, …

Kestra Medical Technologies (KMTS) Nears Its Fair Value, Is The Stock Already Fully Valued?

Kestra Medical Technologies (KMTS) has seen recent positive share price momentum, with its stock closing at US$27.74. While a common narrative suggests the stock is undervalued with a fair value of $28 based on ambitious growth assumptions, other metrics like the P/S ratio indicate …

Praxis Precision Medicines (PRAX): Orbis, Allan Gray disclose 5.5% ownership stake

Orbis Investment Management Ltd and Allan Gray Australia Pty Ltd have jointly disclosed a 5.5% ownership stake in Praxis Precision Medicines (PRAX), amounting to 1,529,788 shares of common stock as of June 30, 2026. Orbis holds the majority with 1,526,680 shares, while Allan Gray …

(PRAX) and the Role of Price-Sensitive Allocations

This article provides a detailed AI-driven analysis of Praxis Precision Medicines Inc. (NASDAQ: PRAX), highlighting a strong overweight bias across all time horizons. It outlines specific institutional trading strategies including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis. The report …

TransMedics Group, Inc. Investor News: Rosen Law Firm

The Rosen Law Firm has announced an investigation into potential breaches of fiduciary duties by the directors and officers of TransMedics Group, Inc. (NASDAQ: TMDX). The firm is encouraging shareholders of TransMedics Group to visit its website or contact them for more information regarding …

Brandes Investment Partners reports 14.9% Utah Medical Products (UTMD) stake

Medicenna Therapeutics Corp. Reports Earnings Results for the First Quarter Ended June 30, 2026

Is Alpha Tau Medical’s (DRTS) Steepening Loss Curve Reframing Its High-Risk Innovation Strategy?

Alpha Tau Medical (DRTS) reported a significant widening of its net loss to US$68.75 million in the first half of 2026, up from US$18.81 million a year prior, leading to increased concerns about its funding risk. Despite the company's focus on clinical progress for …

Solas Capital discloses 9.99% Modular Medical (MODD) position via stock and warrants

Solas Capital Management, LLC and Frederick Tucker Golden have reported an amended beneficial ownership of 9.99% in Modular Medical, Inc. (MODD). This stake comprises 552,171 shares, including common stock and shares issuable upon warrant exercise, with shared voting and dispositive power. The filing details …

Shanghai HeartCare Seeks Shareholder Approval for Sci-Tech Board A-Share Issuance

Shanghai HeartCare Plans A Share Issue and Sci-Tech Board Listing

ICU Medical (ICUI) Insider Sells 5,417 Shares: VP, GM-Infusion Capital Daniel Woolson Reduces Stake

Daniel Woolson, VP, GM-Infusion Capital at ICU Medical Inc (ICUI), sold 5,417 shares of the company on August 13, 2026, bringing his total ownership to 17,062 shares. This transaction is part of a trend where insiders at ICU Medical have generally been selling more …

Fischer Medical Ventures Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Sell Alert: Daniel Woolson Cashes Out $982K In ICU Medical Stock

Daniel Woolson, VP at ICU Medical (NASDAQ: ICUI), recently sold 5,417 shares of the company's stock for a total transaction value of $982,264, as disclosed in an SEC filing. This insider transaction occurred on August 13, leading to a slight dip in ICU Medical's …

Armistice Capital (OFIX) discloses 3.26M-share, 8.01% Orthofix Medical stake

Armistice Capital, LLC and Steven Boyd have reported an updated beneficial ownership stake of 8.01% in Orthofix Medical Inc., totaling 3,264,000 shares. This disclosure, made via an Amendment No. 8 to their Schedule 13G, indicates shared voting and dispositive power over these shares, which …

Mobia Medical, Inc. - Common Stock MOBI

Mobia Medical, Inc. (NASDAQ:MOBI) reported strong second-quarter results with revenue reaching $13.5 million, marking a 102% increase year-over-year. This growth is attributed to the expanded adoption of its Vivistim paired vagus nerve stimulation therapy within stroke-care programs.

Armistice Capital reports 9.99% ownership of Tenon Medical (TNON) through Master Fund

Armistice Capital, LLC and Steven Boyd have reported a 9.99% beneficial ownership stake in Tenon Medical, Inc. (TNON) through Armistice Capital Master Fund Ltd. This ownership, totaling 54,554 shares, grants them shared voting and dispositive power. The filing specifies that the Master Fund retains …

Woodline Partners discloses 8.1% CalciMedica (CALC) stake and sole voting power

Woodline Partners LP has reported a beneficial ownership of 8.1% in CalciMedica, Inc., totaling 2,489,729 shares of common stock. The investment firm, acting as an adviser to Woodline Master Fund LP, holds sole voting and dispositive power over these shares. This disclosure, made via …

Armistice Capital (TMCI) discloses 6.36M-share Treace Medical ownership stake

Armistice Capital, LLC and Steven Boyd have reported a beneficial ownership stake of 6,364,000 shares in Treace Medical Concepts, Inc. (TMCI), representing 9.79% of the outstanding common stock. This ownership is held directly by Armistice Capital Master Fund Ltd., with Armistice Capital serving as …